BIOMARKER ANALYSIS SERVICES
Mercodia offers a wide range of bioanalytical testing solutions, including large molecules, biomarkers, biosimilars, peptides, and oligonucleotides. Our services are tailored to support pharmaceutical and biotechnology companies at every stage of drug development. Understanding the specific context of use of a biomarker is essential for designing a cost- and time-effective bioanalytical strategy.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
BIOMARKER ANALYSIS SERVICES
Biomarker-driven drug development is widely used and has the potential to make drug discovery, development, and approval processes more efficient while improving patient outcomes. The data derived from biomarkers plays a key role in decision-making throughout the entire drug development pipeline, from drug mode of action, efficacy, and safety assessments to patient stratification and evaluation of clinical trial endpoints.
Mercodia understand that the specific context of biomarker use is crucial for designing a bioanalytical strategy that is both cost-effective and time efficient. Our experts provide valuable insights to help you tailor your strategy to precisely fit the needs of your study.
Mercodia offer an extensive portfolio featuring 500+ biomarkers and panels. We are continuously expanding our offerings to enable healthcare providers, researchers, and clinicians to address a broad spectrum of clinical and research questions.
Can't find the specific biomarker you're looking for? No problem! Contact us, and our dedicated team will work with you to provide a customized solution that aligns with your unique requirements.
Important aspects to consider about GLP-1 and GIP
Reports showing that glucagon-like peptide (GLP-1) lowers glucose levels, and glucose-dependent insulinotropic polypeptide (GIP) stimulates insulin secretion led to the development of the first GLP-1 receptor agonist exenatide, followed by the dual GIP and GLP-1 receptor agonist tirzepatide. Uncover the importance of accurate quantitative methods for the precise measurements of these molecules, and explore some of the significant analytical factors that should be considered when measuring circulating GLP-1 and GIP.
